Oncology
Oncology
Oncology
Mid-Infrared Imaging Made Practical for Medicine by Danish Researchers
Different wavelengths of light reveal the world in unique ways, but some are hard to see using the human eye and modern imaging technologies. Mid-infrared light, for example, can be used to look at a variety of biological processes in the body,...
Oncology
Nexus Ultrasonic Surgical Platform from Misonix FDA Cleared
Mixonix, a Farmingdale, New York company that specializes in ultrasonic devices for surgical applications such as osteotomies and debridements, won FDA clearance for the new Nexus surgical platform. The Nexus combines the capabilities of...
Oncology
Avenda Health Uses Artificial Intelligence to Improve Prostate Cancer Treatment
Prostate cancer affects 1 in 9 men and is one of the most common cancers in the United States. Due to the close anatomical association between the prostate and nearby organs, well-known complications of prostate cancer treatment are urinary...
Oncology
Mini-Brain Platform Mimics Human Brain to Help Develop Drugs, Test Therapies
Studying the effect of potential therapies on the human brain is exceedingly difficult. Laboratory animals have proven to be less than ideal as mimics for identifying how a given therapy will work in people, leading to exceedingly long and...
Oncology
3D Ultrasound Developed to Guide Treatment of Gynecological Cancers
Researchers at Western University, London Health Sciences Centre, and Lawson Health Research Institute, all in Canada, have developed and tested a new 3D ultrasound system. Designed to improve the accuracy of interstitial brachytherapy, a...
Oncology
Liquid Biopsy for Monitoring Transplanted Stem Cells
Researchers from the University of Maryland, University of Pennsylvania, and Emory University have demonstrated that a blood test can be used to track the efficacy of transplanted stem cells. They analyzed tiny cellular components called...
Oncology
Magnetic Beads Strip Blood Samples to Allow Circulating Tumor Cell Isolation
Researchers at the University of Georgia have developed a microfluidic chip to isolate circulating tumor cells (CTCs) from blood samples. Unlike other devices, this new chip uses magnetic microbeads to strip all the cells from the blood, leaving...
Oncology
Synthetic Proteins Designed to Halt Growth of Cancers
Stanford University scientists have developed a novel approach to halting the growth of cancer cells while preserving normal function in healthy cells. The research was published in journal Science, and though it was so far conducted only on...
Oncology
System Separates, Sequences Circulating Tumor Cells from Whole Blood
Engineers at the University of Michigan have developed a high speed microfluidic chip that can separate circulating tumor cells (CTCs) from whole blood and analyze them. The technology, which may make biopsies and other diagnostic tests...
Oncology
Your information will never be shared with any third party.